Detalles de la búsqueda
1.
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.
Leukemia
; 32(3): 774-787, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28804127
2.
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing.
Blood Cancer J
; 5: e309, 2015 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25933373
3.
Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKß.
Oncogene
; 32(41): 4892-902, 2013 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23178494
4.
CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.
Oncogene
; 31(39): 4266-78, 2012 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22249265
5.
HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation.
Oncogene
; 31(10): 1299-310, 2012 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-21785461
6.
Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.
Oncogene
; 31(29): 3444-56, 2012 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22120715
7.
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.
Oncogene
; 30(12): 1436-48, 2011 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21057535
Resultados
1 -
7
de 7
1
Próxima >
>>